The expression of SIRT2 is decreased in serous ovarian cancer, and down-regulation of SIRT2 promotes the expression of cyclin-dependent kinase 4 (CDK4), thereby promoting the proliferation, migration and invasion of serous ovarian cancer cells in vitro (48). The gene discussed is SIRT2; the disease is ovarian serous adenocarcinoma.